JP2025508192A5 - - Google Patents

Info

Publication number
JP2025508192A5
JP2025508192A5 JP2024554912A JP2024554912A JP2025508192A5 JP 2025508192 A5 JP2025508192 A5 JP 2025508192A5 JP 2024554912 A JP2024554912 A JP 2024554912A JP 2024554912 A JP2024554912 A JP 2024554912A JP 2025508192 A5 JP2025508192 A5 JP 2025508192A5
Authority
JP
Japan
Prior art keywords
hydrocarbyl
membered
general formula
optionally substituted
halohydrocarbyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024554912A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025508192A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2023/080775 external-priority patent/WO2023174175A1/zh
Publication of JP2025508192A publication Critical patent/JP2025508192A/ja
Publication of JP2025508192A5 publication Critical patent/JP2025508192A5/ja
Pending legal-status Critical Current

Links

JP2024554912A 2022-03-17 2023-03-10 Kif18a阻害剤 Pending JP2025508192A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN202210266719.4 2022-03-17
CN202210266719 2022-03-17
PCT/CN2023/080775 WO2023174175A1 (zh) 2022-03-17 2023-03-10 Kif18a抑制剂

Publications (2)

Publication Number Publication Date
JP2025508192A JP2025508192A (ja) 2025-03-21
JP2025508192A5 true JP2025508192A5 (enExample) 2026-03-18

Family

ID=88022235

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024554912A Pending JP2025508192A (ja) 2022-03-17 2023-03-10 Kif18a阻害剤

Country Status (7)

Country Link
US (1) US20250197382A1 (enExample)
EP (1) EP4495113A4 (enExample)
JP (1) JP2025508192A (enExample)
CN (1) CN118613478A (enExample)
AU (1) AU2023236101A1 (enExample)
CA (1) CA3246028A1 (enExample)
WO (1) WO2023174175A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20250382298A1 (en) * 2022-06-30 2025-12-18 Suzhou Genhouse Bio Co., Ltd. Nitrogen-containing compound and use thereof
WO2024022508A1 (zh) * 2022-07-29 2024-02-01 武汉人福创新药物研发中心有限公司 Kif18a抑制剂及用途
CR20250087A (es) 2022-08-18 2025-07-11 Accent Therapeutics Inc Inhibidores de kif18a y usos de estos
AU2023337160A1 (en) * 2022-09-08 2025-03-20 Changchun Genescience Pharmaceutical Co., Ltd. Kif18a inhibitor compound, and pharmaceutical composition and preparation method therefor and use thereof
WO2024051812A1 (zh) * 2022-09-09 2024-03-14 先声再明医药有限公司 酰胺类化合物、其组合物及用途
WO2024067465A1 (zh) * 2022-09-30 2024-04-04 山东轩竹医药科技有限公司 Kif18a抑制剂
CN117917405A (zh) * 2022-10-21 2024-04-23 杭州邦顺制药有限公司 Kif18a蛋白抑制剂
JP2025538601A (ja) * 2022-11-24 2025-11-28 インベンティスバイオ カンパニー リミテッド 複素環化合物、その製造方法および用途
JP2026508745A (ja) * 2022-12-02 2026-03-12 シェンチェン ジョングァー バイオロジカル テクノロジー カンパニー リミテッド アミド又はウレア系化合物
CN120641408A (zh) * 2022-12-16 2025-09-12 抟相医药(上海)有限公司 含氮化合物、药物组合物及其用途
US20260209248A1 (en) * 2022-12-28 2026-07-23 Insilico Medicine Ip Limited Inhibitors of kif18a and uses thereof
WO2024149189A1 (zh) * 2023-01-09 2024-07-18 浙江海正药业股份有限公司 芳香酰胺类衍生物及其制备方法和用途
KR20250154490A (ko) * 2023-03-10 2025-10-28 쯔지앙 하이썬 파머슈티컬 컴퍼니, 리미티드 방향족 아미드 유도체, 이의 제조 방법, 및 그의 용도
CN121002013A (zh) * 2023-04-18 2025-11-21 南京同诺康医药科技有限公司 Kif18a抑制剂及其制备方法和用途
WO2025167861A1 (zh) * 2024-02-06 2025-08-14 上海齐鲁制药研究中心有限公司 螺环kif18a抑制剂
WO2025190364A1 (zh) * 2024-03-14 2025-09-18 山东轩竹医药科技有限公司 Kif18a抑制剂及其用途
WO2025201531A1 (zh) * 2024-03-29 2025-10-02 深圳众格生物科技有限公司 三环类化合物及其用途
WO2025242166A1 (en) * 2024-05-22 2025-11-27 InventisBio Co., Ltd. Heterocyclic compounds, preparation methods and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA54550A (fr) * 2018-12-20 2022-03-30 Amgen Inc Inhibiteurs de kif18a
AU2019401495B2 (en) * 2018-12-20 2025-06-26 Amgen Inc. Heteroaryl amides useful as KIF18A inhibitors
IL283639B2 (en) * 2018-12-20 2024-06-01 Amgen Inc Kif18a inhibitors
AU2020325115B2 (en) * 2019-08-02 2026-03-12 Amgen Inc. Pyridine derivatives as KIF18A inhibitors
JP7699100B2 (ja) * 2019-08-02 2025-06-26 アムジエン・インコーポレーテツド Kif18a阻害剤
US20220289724A1 (en) * 2019-08-02 2022-09-15 Amgen Inc. Kif18a inhibitors
JP2023521802A (ja) * 2020-04-14 2023-05-25 アムジエン・インコーポレーテツド 新生物疾患の処置のためのkif18a阻害剤
EP4524136A4 (en) * 2022-05-13 2025-08-06 Shanghai Apeiron Therapeutics Company Ltd KINESIN INHIBITOR KIF18A AND ITS USE

Similar Documents

Publication Publication Date Title
JP2024542199A5 (enExample)
JP2023515617A5 (enExample)
KR102244937B1 (ko) 글리옥사미드 치환된 피롤아미드 유도체 및 b형 간염 치료용 의약으로서의 이의 용도
JP2024522990A5 (enExample)
JP2023515618A5 (enExample)
JP2024518554A5 (enExample)
JP2024529839A5 (enExample)
JP2023515620A5 (enExample)
JP2024530952A5 (enExample)
JP2021514001A5 (enExample)
WO2001042241A1 (en) Substituted pyridazines having cytokine inhibitory activity
JP2016500661A5 (enExample)
AR054787A1 (es) Derivados de piperidinas utiles como antagonistas de histamina h3
JP2019515952A5 (enExample)
RU2009119290A (ru) Производные гидантоина, используемые в качестве ингибиторов ммр
JP2017526614A5 (enExample)
JP2021522262A5 (enExample)
JP2023528421A5 (enExample)
JP2024536869A5 (enExample)
JP2021528405A5 (enExample)
JP2005513125A5 (enExample)
JP2025509697A5 (enExample)
JP2023516235A5 (enExample)
JP2008516968A5 (enExample)
RU2002133208A (ru) Замещенные 1-аминоалкиллактамы и их применение в качестве антагонистов мускариновых рецепторов